Literature DB >> 35085099

RADIomic Spatial TexturAl Descriptor (RADISTAT): Quantifying Spatial Organization of Imaging Heterogeneity Associated With Tumor Response to Treatment.

Jacob T Antunes, Marwa Ismail, Imran Hossain, Zhoumengdi Wang, Prateek Prasanna, Anant Madabhushi, Pallavi Tiwari, Satish E Viswanath.   

Abstract

Localized disease heterogeneity on imaging extracted via radiomics approaches have recently been associated with disease prognosis and treatment response. Traditionally, radiomics analyses leverage texture operators to derive voxel- or region-wise feature values towards quantifying subtle variations in image appearance within a region-of-interest (ROI). With the goal of mining additional voxel-wise texture patterns from radiomic "expression maps", we introduce a new RADIomic Spatial TexturAl descripTor (RADISTAT). This was driven by the hypothesis that quantifying spatial organization of texture patterns within an ROI could allow for better capturing interactions between different tissue classes present in a given region; thus enabling more accurate characterization of disease or response phenotypes. RADISTAT involves: (a) robustly identifying sub-compartments of low, intermediate, and high radiomic expression (i.e. heterogeneity) in a feature map and (b) quantifying spatial organization of sub-compartments via graph interactions. RADISTAT was evaluated in two clinically challenging problems: (1) discriminating nodal/distant metastasis from metastasis-free rectal cancer patients on post-chemoradiation T2w MRI, and (2) distinguishing tumor progression from pseudo-progression in glioblastoma multiforme using post-chemoradiation T1w MRI. Across over 800 experiments, RADISTAT yielded a consistent discriminatory signature for tumor progression (GBM) and disease metastasis (RCa); where its sub-compartments were associated with pathologic tissue types (fibrosis or tumor, determined via fusion of MRI and pathology). In a multi-institutional setting for both clinical problems, RADISTAT resulted in higher classifier performance (11% improvement in AUC, on average) compared to radiomic descriptors. Furthermore, combining RADISTAT with radiomic descriptors resulted in significantly improved performance compared to using radiomic descriptors alone.

Entities:  

Mesh:

Year:  2022        PMID: 35085099      PMCID: PMC9295632          DOI: 10.1109/JBHI.2022.3146778

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   7.021


  43 in total

1.  A graph-based lesion characterization and deep embedding approach for improved computer-aided diagnosis of nonmass breast MRI lesions.

Authors:  Cristina Gallego-Ortiz; Anne L Martel
Journal:  Med Image Anal       Date:  2018-11-02       Impact factor: 8.545

2.  Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.

Authors:  Niha Beig; Salendra Singh; Kaustav Bera; Prateek Prasanna; Gagandeep Singh; Jonathan Chen; Anas Saeed Bamashmos; Addison Barnett; Kyle Hunter; Volodymyr Statsevych; Virginia B Hill; Vinay Varadan; Anant Madabhushi; Manmeet S Ahluwalia; Pallavi Tiwari
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

3.  AJCC 8th Edition: Colorectal Cancer.

Authors:  Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2018-04-03       Impact factor: 5.344

4.  Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.

Authors:  Prateek Prasanna; Jay Patel; Sasan Partovi; Anant Madabhushi; Pallavi Tiwari
Journal:  Eur Radiol       Date:  2016-10-24       Impact factor: 5.315

Review 5.  Radiomics: the process and the challenges.

Authors:  Virendra Kumar; Yuhua Gu; Satrajit Basu; Anders Berglund; Steven A Eschrich; Matthew B Schabath; Kenneth Forster; Hugo J W L Aerts; Andre Dekker; David Fenstermacher; Dmitry B Goldgof; Lawrence O Hall; Philippe Lambin; Yoganand Balagurunathan; Robert A Gatenby; Robert J Gillies
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

6.  Pathological features of rectal cancer after preoperative radiochemotherapy.

Authors:  O Dworak; L Keilholz; A Hoffmann
Journal:  Int J Colorectal Dis       Date:  1997       Impact factor: 2.571

7.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

8.  Radiomics-Based Preoperative Prediction of Lymph Node Status Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer.

Authors:  Xuezhi Zhou; Yongju Yi; Zhenyu Liu; Zhiyang Zhou; Bingjia Lai; Kai Sun; Longfei Li; Liyu Huang; Yanqiu Feng; Wuteng Cao; Jie Tian
Journal:  Front Oncol       Date:  2020-05-11       Impact factor: 6.244

Review 9.  The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence.

Authors:  Kashif Parvez; Aatif Parvez; Gelareh Zadeh
Journal:  Int J Mol Sci       Date:  2014-07-03       Impact factor: 5.923

10.  Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Authors:  Gregory Penzias; Asha Singanamalli; Robin Elliott; Jay Gollamudi; Natalie Shih; Michael Feldman; Phillip D Stricker; Warick Delprado; Sarita Tiwari; Maret Böhm; Anne-Maree Haynes; Lee Ponsky; Pingfu Fu; Pallavi Tiwari; Satish Viswanath; Anant Madabhushi
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.